RCEL Alert: Kirby McInerney LLP Encourages AVITA Medical, Inc. Investors to Inquire about Investigation

Core Viewpoint - AVITA Medical, Inc. is under investigation for potential violations of federal securities laws or unlawful business practices following the release of its second quarter 2025 financial results, which indicated a significant backlog in unpaid provider claims for its Recell procedures [1]. Financial Performance - On August 7, 2025, AVITA Medical reported its second quarter 2025 financial results, highlighting a six-month backlog in unpaid provider claims for its Recell procedures [1].